Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of Interventional Cardiac Electrophysiology
Erschienen in:

17.10.2023

Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life

verfasst von: Chadi Tabaja, Arwa Younis, Pasquale Santangeli, Ruth Madden, Tyler Taigen, Medhat Farwati, Katsuhide Hayashi, Lorenzo Braghieri, John Rickard, Benjamin M. Klein, Aritra Paul, Thomas J. Dresing, David O. Martin, Mandeep Bhargava, Mohamed Kanj, Jakub Sroubek, Hiroshi Nakagawa, Walid I. Saliba, Oussama M. Wazni, Ayman A. Hussein

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Atrial fibrillation (AF) risk increases with age. We aim to assess the efficacy and safety of catheter ablation in the older population.

Methods

All patients undergoing AF ablation (2013–2021) at our institution were enrolled in a prospectively maintained registry. The primary endpoint was AF recurrence. Patients were divided into 3 groups: non-elderly (< 65 years), elderly (65–75 years), and very elderly (> 75 years). Patient surveys at baseline and during follow-up were used to calculate quality of life (QoL) metrics: the AF severity score as well as the AF burden.

Results

A total of 7020 patients were included (42% non-elderly, 42% elderly, and 16% very elderly). Periprocedural major complications were low (< 1.5%) and similar in all groups besides pericardial effusion which was more frequent with older age and similar between the elderly and very elderly. At 3 years, AF recurrence for persistent AF (PersAF) was highest in the very elderly group (48%), followed by the elderly group (42%), and was the lowest in the non-elderly group (36%). In paroxysmal AF (PAF), there was no difference in AF recurrence between the elderly and non-elderly, while the very elderly remained associated with a significantly increased risk. Multivariable Cox analysis confirmed these findings (PersAF; elderly: HR = 1.23, P = 0.003; very elderly: HR = 1.44, P < 0.001) (PAF; elderly: HR = 1.04, P = 0.62; very elderly: HR = 1.30, P = 0.01). Catheter ablation resulted in a significant improvement in quality of life, irrespective of age group.

Conclusion

Catheter ablation in elderly and very elderly patients is safe, efficacious, and associated with QoL benefits. Overall, major complications were minimal and did not differ significantly between age groups, with the exception of pericardial effusions which were higher in the elderly and very elderly compared to non-elderly adults. Very elderly patients had a higher rate of AF recurrence when compared with elderly or non-elderly patients. Nevertheless, ablation resulted in a remarkable improvement in QoL and a reduction of AF burden and AF symptoms with a similar magnitude, irrespective of age.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation Analysis and implications. Arch Intern Med. 1995;155:469–73.CrossRefPubMed
3.
Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, Benjamin EJ, Curtis LH. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries 1993–2007. Circ: Cardiovasc Qual Outcomes. 2012;5:85–93.PubMed
4.
Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck K-H, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, Investigators ftC. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261–74.CrossRefPubMedPubMedCentral
5.
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck K-H, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305–16.CrossRefPubMed
6.
Bahnson TD, Giczewska A, Mark DB, Russo AM, Monahan KH, Al-Khalidi HR, Silverstein AP, Poole JE, Lee KL, Packer DL. Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial. Circulation. 2022;145:796–804.CrossRefPubMed
7.
8.
Bassiouny M, Saliba W, Hussein A, Rickard J, Diab M, Aman W, Dresing T, Callahan TT, Bhargava M, Martin DO, Shao M, Baranowski B, Tarakji K, Tchou PJ, Hakim A, Kanj M, Lindsay B, Wazni O. Randomized study of persistent atrial fibrillation ablation: ablate in sinus rhythm versus ablate complex-fractionated atrial electrograms in atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e003596.CrossRefPubMed
9.
Hussein AA, Lindsay B, Madden R, Martin D, Saliba WI, Tarakji KG, Saqi B, Rausch DJ, Dresing T, Callahan T, Chung MK, Baranowski B, Bhargava M, Cantillon D, Rickard J, Kanj M, Tchou P, Wilkoff BL, Nissen SE, Wazni OM. New model of automated patient-reported outcomes applied in atrial fibrillation. Circ Arrhythm Electrophysiol. 2019;12:e006986.CrossRefPubMed
10.
Farwati M, Wazni OM, Tarakji KG, Diab M, Scandinaro A, Amin M, Zmaili M, Bazarbashi N, Dikilitas O, Nakagawa H, Kuroda S, Kanj M, Dresing TJ, Callahan TD, Bhargava M, Baranowski B, Rickard J, Cantillon DJ, Tchou PJ, Saliba WI, Hussein AA. Super and nonresponders to catheter ablation for atrial fibrillation: a quality-of-life assessment using patient reported outcomes. Circ Arrhythm Electrophysiol. 2021;14:e009938.CrossRefPubMed
11.
Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, Arribas F, Fernández-Lozano I, Bodegas A, Cobos A, Matía R, Pérez-Villacastín J, Guerra JM, Ávila P, López-Gil M, Castro V, Arana JI, Brugada J, Investigators oboS. Catheter ablation vs antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2013;35:501–7.CrossRefPubMedPubMedCentral
12.
Forleo GB, Mantica M, de Luca L, Leo R, Santini L, Panigada S, de Sanctis V, Pappalardo A, Laurenzi F, Avella A, Casella M, Russo AD, Romeo F, Pelargonio G, Tondo C. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20:22–8.CrossRefPubMed
13.
Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study)†. Eur Heart J. 2005;27:216–21.CrossRefPubMed
14.
Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation. Circulation. 2008;118:2498–505.CrossRefPubMed
15.
Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27.CrossRefPubMed
16.
Bhargava M, Marrouche NF, Martin DO, Schweikert RA, Saliba W, Saad EB, Bash D, Williams-Andrews M, Rossillo A, Erciyes D, Khaykin Y, Burkhardt JD, Joseph G, Tchou PJ, Natale A. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter. J Cardiovasc Electrophysiol. 2004;15:8–13.CrossRefPubMed
17.
Zado E, Callans DJ, Riley M, Hutchinson M, Garcia F, Bala R, Lin D, Cooper J, Verdino R, Russo AM, Dixit S, Gerstenfeld E, Marchlinski FE. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621–6.CrossRefPubMed
18.
Corrado A, Patel D, Riedlbauchova L, Fahmy TS, Themistoclakis S, Bonso A, Rossillo A, Hao S, Schweikert RA, Cummings JE, Bhargava M, Burkhardt D, Saliba W, Raviele A, Natale A. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovascr Electrophysiol. 2008;19:807–11.CrossRef
19.
Kusumoto F, Prussak K, Wiesinger M, Pullen T, Lynady C. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol. 2009;25:31–5.CrossRefPubMed
20.
Romero J, Ogunbayo G, Elayi SC, Darrat Y, Rios SA, Diaz JC, Alviz I, Cerna L, Gabr M, Chernobelsky E, Mohanty S, Trivedi CG, Della Rocca DG, Natale A, Di Biase L. Safety of catheter ablation for atrial fibrillation in the octogenarian population. J Cardiovasc Electrophysiol. 2019;30:2686–93.CrossRefPubMed
21.
Prasitlumkum N, Tokavanich N, Trongtorsak A, Cheungpasitporn W, Kewcharoen J, Chokesuwattanaskul R, Akoum N, Jared Bunch T, Navaravong L. Catheter ablation for atrial fibrillation in the elderly >75 years old: systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2022;33:1435–49.CrossRefPubMed
22.
Kawamura I, Aikawa T, Yokoyama Y, Takagi H, Kuno T. Catheter ablation for atrial fibrillation in elderly patients: systematic review and a meta-analysis. Pacing Clin Electrophysiol. 2022;45:59–71.CrossRefPubMed
23.
Blandino A, Toso E, Scaglione M, Anselmino M, Ferraris F, Sardi D, Battaglia A, Gaita F. Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:731–8.CrossRefPubMed
24.
Moser JM, Willems S, Andresen D, Brachmann J, Eckardt L, Hoffmann E, Kuck KH, Lewalter T, Schumacher B, Spitzer SG, Hochadel M, Senges J, Hoffmann BA. Complication rates of catheter ablation of atrial fibrillation in patients aged ≥75 years versus <75 years-results from the German ablation registry. J Cardiovasc Electrophysiol. 2017;28:258–65.CrossRefPubMed
25.
Fleg JL, Strait J. Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev. 2012;17:545–54.CrossRefPubMedPubMedCentral
26.
Santangeli P, Di Biase L, Mohanty P, Burkhardt JD, Horton R, Bai R, Mohanty S, Pump A, Gibson D, Couts L, Hongo R, Beheiry S, Natale A. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23:687–93.CrossRefPubMed
27.
Natale V, Mohanty S, Trivedi C, Baqai FM, Gallinghouse J, Della Rocca DG, Gianni C, MacDonald B, Mayedo A, Burkhardt JD, Gallinghouse GJ, Al-Ahmad A, Horton R, Bassiouny M, Di Biase L, Natale A. Arrhythmia profile and ablation-outcome in elderly women with atrial fibrillation undergoing first catheter ablation. Pacing Clin Electrophysiol. 2021;44:835–42.CrossRefPubMed
28.
den Uijl DW, Cabanelas N, Benito EM, Figueras R, Alarcón F, Borràs R, Prat S, Guasch E, Perea R, Sitges M, Brugada J, Berruezo A, Mont L. Impact of left atrial volume, sphericity, and fibrosis on the outcome of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:740–6.CrossRef
29.
Akoum N, Mahnkopf C, Kholmovski EG, Brachmann J, Marrouche NF. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. EP Europace. 2017;20:1086–92.CrossRef
30.
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–25.CrossRefPubMed
31.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–47.CrossRefPubMed
32.
Wasmer K, Eckardt L, Breithardt G. Predisposing factors for atrial fibrillation in the elderly. J Geriatr Cardiol. 2017;14:179–84.PubMedPubMedCentral
33.
Hussein AA, Saliba WI, Barakat A, Bassiouny M, Chamsi-Pasha M, Al-Bawardy R, Hakim A, Tarakji K, Baranowski B, Cantillon D, Dresing T, Tchou P, Martin DO, Varma N, Bhargava M, Callahan T, Niebauer M, Kanj M, Chung M, Natale A, Lindsay BD, Wazni OM. Radiofrequency ablation of persistent atrial fibrillation. Circ: Arrhythmia Electrophysiol. 2016;9:e003669.
34.
Andrade JG, Deyell MW, Verma A, Macle L, Champagne J, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Khairy P, Nattel S. Association of atrial fibrillation episode duration with arrhythmia recurrence following ablation: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3:e208748–e208748.CrossRefPubMedPubMedCentral
35.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20:157–208.CrossRefPubMed
36.
Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace. 2011;13:329–45.CrossRefPubMed
Metadaten
Titel
Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life
verfasst von
Chadi Tabaja
Arwa Younis
Pasquale Santangeli
Ruth Madden
Tyler Taigen
Medhat Farwati
Katsuhide Hayashi
Lorenzo Braghieri
John Rickard
Benjamin M. Klein
Aritra Paul
Thomas J. Dresing
David O. Martin
Mandeep Bhargava
Mohamed Kanj
Jakub Sroubek
Hiroshi Nakagawa
Walid I. Saliba
Oussama M. Wazni
Ayman A. Hussein
Publikationsdatum
17.10.2023
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 5/2024
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-023-01659-w

Weitere Artikel der Ausgabe 5/2024

Association between P-wave terminal force in lead V1 and extent of left atrial low-voltage substrate in older patients with paroxysmal atrial fibrillation

A proposed index of myocardial staining for vein of Marshall ethanol infusion: an Italian single-center experience

  • Open Access
  • REVIEW

Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial

Intracerebral hemorrhage mortality in individuals with atrial fibrillation: a nationwide analysis of mortality trends in the United States

Failure of intravenous nifekalant cardioversion as an independent predictor for persistent atrial fibrillation recurrence after catheter ablation

Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach

  • Case Reports

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Kardiologie

Blutdruck am Belastungsende zeigt kardiovaskuläres Risiko

Diverse Blutdruckparameter während der Ergometrie sind schon auf ihre Aussagekraft, Mortalität und kardiovaskuläres Risiko betreffend, hin abgeklopft worden. Nun hat auch das Druckverhalten am Ende der Belastung im Fokus einer Studie gestanden.

Lp(a) wird zu selten gemessen

Laut europäischer Dyslipidämie-Leitlinie sollte die Bestimmung der Serumkonzentration von Lipoprotein (a) mindestens einmal im Leben jedes Erwachsenen erwogen werden. Tatsächlich wird die Messung selbst kardiovaskulär gefährdeten Personen nur selten zuteil.

Neue US-Leitlinie zum Management bei akutem Koronarsyndrom

In den USA ist die Leitlinie zum Management bei akutem Koronarsyndrom aktualisiert worden. In Europa erfolgte das neueste Guideline-Update dazu bereits 2023. Gehen beide Leitlinien konform oder gibt es nennenswerte Differenzen? 

Mechanische Herzklappe beschert jüngeren Betroffenen längeres Leben

Patienten und Patientinnen bevorzugen bioprothetische Herzklappen gegenüber mechanischen Klappenprothesen. Diese Wahl könnte sich zumindest für jüngere Patienten nachteilig auswirken: Ihnen bietet eine mechanische Klappe anscheinend einen Überlebensvorteil.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise